NADPH Oxidase Pathway Is Involved in Aortic Contraction Induced by A3 Adenosine Receptor in Mice by El-Awady, M. S. et al.
NADPH Oxidase Pathway Is Involved in Aortic Contraction
Induced by A3 Adenosine Receptor in Mice
Mohammed S. El-Awady, Habib R. Ansari, Daniel Fil, Stephen L. Tilley,
and S. Jamal Mustafa
Department of Physiology and Pharmacology and Center for Cardiovascular and Respiratory Sciences, West Virginia
University, Morgantown, West Virginia (M.S.E., D.F., S.J.M.); Department of Biosciences, Jamia Millia Islamia, New Delhi, India
(H.R.A.); and Department of Medicine, University of North Carolina, Chapel Hill, North Carolina (S.L.T.)
Received February 18, 2011; accepted May 20, 2011
ABSTRACT
The NADPH oxidase (Nox) subunits 1, 2 (gp91 phox), and 4 are the
major sources for reactive oxygen species (ROS) in vascular tis-
sues. In conditions such as ischemia-reperfusion and hypoxia,
both ROS and adenosine are released, suggesting a possible
interaction. Our aim in this study was to examine the A3 adenosine
receptor (A3AR)-induced vascular effects and its relation to ROS
and Nox1, 2, and 4 using aortic tissues from wild-type (WT) and
A3AR knockout (A3KO) mice. The selective A3AR agonist
2-chloro-N6-(3-iodobenzyl)-adenosine-5-N-methyluronamide
(Cl-IBMECA) (1010–105 M) induced contraction of the aorta
from WT but not from A3KO mice, and this contraction was
inhibited by the Nox inhibitor apocynin (105 M) and the ROS
scavengers superoxide dismutase-polyethylene glycol and cata-
lase-polyethylene glycol (100 U/ml each). Cl-IBMECA-induced
contraction was not affected by the mast cell degranulator com-
pound 48/80 (100 g/ml) or the stabilizer cromolyn sodium (104
M). In addition, Cl-IBMECA (107 M) increased intracellular ROS
generation by 35  14% in WT but not in A3KO aorta, and this
increase was inhibited by apocynin (105 M), diphenyleneiodo-
nium chloride (105 M), and the A3AR antagonist 3-propyl-6-ethyl-
5-[(ethylthio)carbonyl]-2 phenyl-4-propyl-3-pyridine carboxylate
(MRS1523) (105 M). Furthermore, Cl-IBMECA selectively in-
creased the protein expression of the Nox2 subunit by 150  15%
in WT but not in A3KO mice without affecting either Nox1 or 4, and
this increase was inhibited by apocynin. The mRNA of Nox2 was
unchanged by Cl-IBMECA in either WT or A3KO aortas. In con-
clusion, A3AR enhances ROS generation, possibly through acti-
vation of Nox2, with subsequent contraction of the mouse aorta.
Introduction
Adenosine is an autacoid that plays an important role in
the regulation of cardiovascular functions. The cardiovascu-
lar effects of adenosine are mediated by activation of four
well known cell surface receptors (A1, A2A, A2B, and A3)
(Tabrizchi and Bedi, 2001; Mustafa et al., 2009). The role of
adenosine receptors (ARs) in vascular contraction and relax-
ation has been studied in several species, A2AAR and A2BAR
showing vasorelaxant effects and A1AR showing vasocon-
stricting effects (Tabrizchi and Bedi, 2001; Ansari et al.,
2007a, 2009). However, the physiological role of A3AR in
vascular responses is not fully characterized, although its
role in myocardial ischemia and reperfusion injury has been
demonstrated (Maddock et al., 2003; Zatta et al., 2006). We
previously demonstrated that activation of A3AR leads to
endothelium-dependent aortic contraction through cyclooxy-
genase-1 (COX-1) using A3AR knockout (A3KO) mice (Ansari
et al., 2007b). A3AR has also been shown to inhibit or nega-
tively modulate coronary flow in isolated mouse heart (Ta-
lukder et al., 2002), to cause vasoconstriction in hamster
arterioles (Shepherd et al., 1996), and to reverse vascular
hyporeactivity after hemorrhagic shock in rats (Zhou et al.,
2010).
NADPH oxidases (Nox) are the major source of reactive
oxygen species (ROS) in the vasculature that play both phys-
iological and pathophysiological roles in the control of vascu-
lar tone (Carlstrom et al., 2009). The family of NADPH oxi-
dases consists of seven members, Nox1–Nox5 and Doux1 and
Doux2 (Schröder, 2010). Among these, Nox1, Nox2, and Nox4
are of relevance in the cardiovascular system. Nox5 is not
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expressed in rodents because of gene deletion (Kawahara et
al., 2007). Endothelial cells express Nox2 and Nox4, whereas
vascular smooth muscle cells express Nox1 and Nox4 (Gör-
lach et al., 2000; Cheng et al., 2001; Sorescu et al., 2004). In
conditions such as ischemia-reperfusion and hypoxia, both
ROS and adenosine are released, suggesting a possible inter-
action between them (Zatta et al., 2006; Gebremedhin et al.,
2010). It is becoming increasingly clear that adenosine may
exhibit some of its actions through modulation of Nox activity
(Ribé et al., 2008; Carlstrom et al., 2009; Jajoo et al., 2009;
Nadeem et al., 2009).
The question arises whether A3AR-induced contraction in
mouse aorta is mediated through ROS from Nox. Our data
indicate that A3AR activation using Cl-IBMECA leads to
aortic contraction in wild-type (WT) but not in A3AR knock-
out (A3KO) mice. In addition, Cl-IBMECA induced intracel-
lular ROS generation through selective activation of the
Nox2 subunit in WT but not in A3KO mice without affecting
Nox1 or 4. The Nox inhibitor apocynin inhibited A3AR-in-
duced aortic contraction, ROS generation, and Nox2 activa-
tion in the aorta of WT mice but not in A3KO mice.
Materials and Methods
All of the experimental protocols were performed according to the
guidelines and approval of the Animal Care and Use Committee at
West Virginia University. A3KO (male/female) mice were generated,
as described previously (Salvatore et al., 2000) and backcrossed 12
generations to the C57BL/6 background. The corresponding WT
(C57BL/6) mice were purchased from Harlan (Indianapolis, IN).
A3KO and their corresponding WT mice (10–12 weeks old) were used
in this study.
Preparation of Isolated Mouse Aorta. The mice were sacri-
ficed by deep anesthesia with pentobarbital sodium (65 mg/kg i.p.)
followed by thoracotomy. The aorta was gently removed and cleaned
of fat and connective tissue. The aorta was cut transversely into four
rings that measured 3 to 4 mm in length with extreme care to avoid
damaging the endothelium. The rings were mounted vertically be-
tween two wire hooks and then suspended in 10-ml organ baths
containing Krebs-Henseleit buffer (KH buffer, pH 7.4) of the follow-
ing composition: 118 mM NaCl, 4.8 mM KCl, 1.2 mM MgSO4, 1.2 mM
KH2PO4, 25 mM NaHCO3, 11 mM glucose, and 2.5 mM CaCl2. The
KH buffer was maintained at 37°C with continuous bubbling of 95%
O2 and 5% CO2. The aortic rings were equilibrated for 90 min with a
resting force of 1 g, with changes of the bathing solution at 15-min
intervals. The changes in isometric tension were monitored contin-
uously with a fixed-range precision force transducer (TSD, 125 C;
BIOPAC Systems, Inc., Goleta, CA) connected to a differential am-
plifier (DA 100B; BIOPAC Systems, Inc.). The data were recorded on
a digital acquisition system and analyzed using Acknowledge 3.5.7
software (BIOPAC Systems, Inc.).
At the end of the equilibration period, aortic rings were contracted
with 50 mM KCl to check their viability. The tissues were then
contracted with phenylephrine (PE, 107 M) to produce consistent
submaximal (90%) response in our experiments. The aortic rings
were then washed several times with KH buffer and allowed to
equilibrate for 30 min before the experimental protocol began.
Experimental Protocol. All experiments were performed in en-
dothelium-intact aortic rings, because we previously showed that
activation of A3AR leads to endothelium-dependent aortic contrac-
tion because of the higher expression of A3AR in endothelium com-
pared with that in aortic smooth muscle in mouse (Ansari et al.,
2007b). The cumulative concentration-response curves for the selec-
tive A3AR agonist Cl-IBMECA (10
10–105 M) were run in parallel
in aortic rings from both WT and A3KO mice. Inhibitors and antag-
onists [apocynin, 105 M; DPI, 105 M; 3-propyl-6-ethyl-5-[(ethyl-
thio)carbonyl]-2 phenyl-4-propyl-3-pyridine carboxylate (MRS1523),
105 M; superoxide dismutase-polyethylene glycol (PEG-SOD), and
catalase-polyethylene glycol (PEG-catalase), 100 U/ml each; cromo-
lyn sodium, 104 M; and compound 48/80, 100 g/ml] were added 30
min before aortic contraction with PE and were present throughout
the experiments.
ROS Generation in Mouse Aorta. For reactive oxygen species
generation, mouse aortic tissues were cut into 3- to 4-mm-lengths
and were first preincubated for 75 min at 37°C in 1 ml of KH buffer.
After this incubation, the aortic tissues were incubated with 100 M
2,7-dichlorofluorescin diacetate (DCFH-DA) for 30 min at 37°C.
DCFH-DA forms a fluorescent product, 2,7-dichlorofluorescein
(DCF), intracellularly upon oxidation with ROS (Wang and Joseph,
1999). Fluorescence caused by DCF in each well was measured and
recorded for 15 min at 485 nm (excitation) and 530 nm (emission)
using a Synergy HT Multi-Mode Microplate Reader (BioTek Instru-
ments, Winooski, VT) with temperature maintained at 37°C. The
background fluorescence caused by buffer and DCF was subtracted
from the total fluorescence in each well caused by aortic rings in the
presence of DCF. Fluorescence intensity units were then normalized
by milligrams of wet weight tissue for each aortic ring and expressed
as arbitrary fluorescence units per milligram of tissue.
Immunoblotting of Nox1, 2, and 4 in Mouse Aorta. The aortic
tissues from both WT and A3KO mice were processed similar to the
organ bath experiments and then incubated in the absence or pres-
ence of the Nox inhibitor apocynin (105 M) for 30 min before treat-
ment with Cl-IBMECA (107 M) for 10 min.
The aortic tissues were homogenized with 6 volumes of ice-cold
tissue lysis buffer consisting of 0.05 M Tris-buffered saline (pH 7.4),
1% Triton X-100, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10
g/ml leupeptin, 1 g/ml pepstatin, 1 mM sodium orthovanadate,
and 1 mM sodium fluoride. Homogenized samples were centrifuged
for 30 min at 12,000g at 4°C. The protein content of the supernatant
was determined using a Bradford protein assay (Bio-Rad Laborato-
ries, Hercules, CA).
Aliquots of the aortic lysates (40 g of protein/well) were separated
on 10% SDS-PAGE. Prestained protein molecular markers (20–112
kDa) were run in parallel. Proteins were transferred to nitrocellulose
membranes and incubated with 5% milk for 1 h to block nonspecific
binding sites. Membranes were then probed with either anti-gp91
phox (anti-Nox2) mouse monoclonal IgG (BD Biosciences, San Jose,
CA) or anti-Nox4 rabbit polyclonal IgG (Abcam, Cambridge, MA) at
a dilution of 1:1000 or anti-Nox1 rabbit polyclonal IgG (Abcam) at a
dilution of 1:500, followed by incubation with secondary antibodies
for 1 h (horseradish peroxidase-conjugated goat anti-mouse or goat
anti-rabbit at 1:10,000 dilution (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA). After extensive washing, membranes were then
stripped and reprobed with monoclonal anti--actin antibody (Santa
Cruz Biotechnology, Inc.) at a dilution of 1:10,000. For detection of
bands, the membranes were treated with a ECL Plus (for Nox2,
Nox4, and -actin) or Advance (for Nox1) Kit (GE Healthcare, Chal-
font St. Giles, Buckinghamshire, UK) for 1 min and subsequently
exposed to ECL Hyperfilm. Relative band intensities were quantified
by densitometry (ImageJ 1.43u; National Institutes of Health,
Bethesda, MD), and each sample was normalized to the -actin
values. Western blot values are expressed as a percentage of control
after densitometric analysis.
Real-Time PCR for Nox2 in Mouse Aorta. Mouse aortic rings
were treated as described previously, and then tissues were snap-
frozen in liquid nitrogen and kept at 80°C. Total RNA was isolated
from the aortic rings by using TRI reagent (MRC Inc., Cincinnati,
OH) followed by purification of the RNA in aqueous phase and
removal of genomic DNA by an RNeasy Plus Micro Kit (QIAGEN,
Hilden, Germany). This was followed by conversion of 0.5 g of total
RNA into cDNA using a High-Capacity cDNA Archive Kit (Applied
Biosystems, Foster City, CA) according to the manufacturer’s in-
structions in a total volume of 20 l. Real-time PCR was performed
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on an ABI PRISM 7300 Detection System (Applied Biosystems)
using TaqMan Universal Master Mix (Applied Biosystems). In brief,
the reaction volume (20 l) included 10 l of 2 TaqMan Universal
Master Mix, 4 l of cDNA, and 1 l of 20 FAM-labeled TaqMan
gene expression assay. TaqMan inventoried Assays-on-Demand gene
expression products were purchased from Applied Biosystems.
A Mm01287743_m1 assay was used for the Nox2 gene. An
Hs999999_s1 assay was used for ribosomal RNA (18S rRNA) as an
endogenous control. The fold difference in expression of target cDNA
was determined by using the comparative CT method. The fold dif-
ference in gene expression of the target was calculated as described
previously (Livak and Schmittgen, 2001).
Drugs Used. Unless stated otherwise, all chemicals were of the
highest grade available and were purchased from Sigma-Aldrich (St.
Louis, MO). DCFH-DA, MRS1523, Cl-IBMECA, and DPI were dis-
solved in dimethyl sulfoxide, whereas apocynin, acetylcholine, PE,
PEG-SOD, and PEG-catalase were dissolved in distilled water. Di-
methyl sulfoxide final concentration in the organ bath had no effect
by itself on the aortic rings.
Data Analysis. All of the experimental values are presented as
means  S.E.M. (n  number of animals). The comparison among
different groups was analyzed by ANOVA followed by the Tukey
multiple comparisons test method as a post hoc test. Comparison
between two groups was assessed by an unpaired t test. P 	 0.05 was
taken as significant. The EC50 for aortic contraction was obtained
from individual curves by nonlinear regression (curve-fit) graphic
analysis. All of the statistical analyses were performed using Graph-
Pad Prism (version 3.0; GraphPad Software Inc., San Diego, CA).
Results
Effect of A3AR Activation on Contractility of WT/
A3KO Mouse Aorta. Incubation of WT aortic rings with
increasing concentrations of the selective A3AR agonist Cl-
IBMECA produced a concentration-dependent contraction
with a pEC50 of 8.22  0.27 (Fig. 1, A and B). The contraction
induced by Cl-IBMECA was insignificant in A3KO aortic
rings. At 107 M, Cl-IBMECA increased contraction signifi-
cantly by 25% in WT, while producing a negligible effect
(6%) in A3KO mouse aorta (Fig. 1A). The contraction in-
duced by Cl-IBMECA in WT aortic rings was significantly
inhibited by preincubation with the Nox inhibitor, apocynin
(105 M). These results suggest that A3AR-mediated contrac-
tion is dependent on Nox activation in mouse aorta.
To further test the involvement of the ROS in the contrac-
tion induced by A3AR activation, PEG-SOD, and PEG-cata-
lase as ROS scavengers were tested against Cl-IBMECA-
induced contraction (Fig. 1C). Preincubation with PEG-(SOD 

catalase) inhibited the contraction induced by Cl-IBMECA in
WT aortic rings without affecting that of the A3KO, indicating
that A3AR activation causes contraction through the release of
ROS.
The role of mast cells in Cl-IBMECA-mediated contraction
was also investigated. Preincubation of aortic rings with
compound 48/80, a mast cell degranulator, or cromolyn so-
dium, a mast cell stabilizer, did not affect the baseline or
Cl-IBMECA-induced contraction (data not shown). These
data suggest that mast cells may not play a significant role in
either control of aortic tone or A3AR-mediated contraction in
this investigation.
Effect of A3AR Activation on ROS Generation from
WT/A3KO Mouse Aorta. Incubation of WT aortic rings with
107 M Cl-IBMECA increased the amount of intracellular
ROS production in WT by 35  14% compared with that in
Fig. 1. Vascular responses to Cl-IBMECA in WT and A3KO mouse aorta.
A, tracing showing the responses to Cl-IBMECA in WT and A3KO mouse
aortic rings. B, effect of apocynin on Cl-IBMECA-induced contraction in
WT and A3KO mouse aorta. C, effect of PEG-(SOD 
 catalase) on Cl-
IBMECA-induced contraction in WT and A3KO mouse aorta. Data are
expressed as the mean  S.E.M. (n  6). , p 	 0.05 compared with the
A3AR KO control group using one-way ANOVA followed by a Tukey
multiple comparison post hoc test.
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corresponding A3KO aortas (Fig. 2A). In contrast, Cl-
IBMECA did not increase ROS production in A3KO aorta.
Preincubation with Nox inhibitors apocynin (105 M) or DPI
(105 M) prevented this increase in ROS production (Fig.
2A), indicating that the source of ROS activated by Cl-
IBMECA is Nox. Likewise, preincubation with the selective
A3AR inhibitor MRS1523 (10
7 M) leads to inhibition of ROS
production induced by Cl-IBMECA (Fig. 2B), confirming that
A3AR activation induces ROS production through Nox.
Effects of A3AR Activation on Nox1, 2, and 4 Protein
Expression in WT/A3KO Mouse Aorta. For further confir-
mation of the role of Nox in the contraction and ROS gener-
ation induced by A3AR activation, the protein expression
levels of Nox1, 2, and 4 subunits were examined. Activation
of A3AR with Cl-IBMECA (10
7 M) selectively increased the
expression of Nox2 in WT aorta by 150  15% compared with
that in the control (Fig. 3A). This increase in Nox2 expression
was inhibited by preincubation with apocynin (105 M),
whereas neither Cl-IBMECA alone nor with apocynin had an
effect on Nox2 expression in A3KO mice aorta (Fig. 3B). On
the other hand, Cl-IBMECA (107 M) had no effect on the
expression of Nox1 (Fig. 4, A and B) or Nox4 (Fig. 4, C and D)
either in WT or in A3KO mice aorta. These data confirm the
selective activation of the Nox2 subunit by A3AR, leading to
ROS generation and contraction in mouse aorta.
Effects of A3AR Activation on Nox2 mRNA Expres-
sion in WT/A3KO Mouse Aorta. Because Nox2 protein
expression was selectively increased by A3AR activation in
WT but not in A3KO mouse aorta, we examined the change in
Nox2 mRNA expression induced by Cl-IBMECA. Of interest,
the mRNA expression of Nox2 was not affected by Cl-
IBMECA in either WT or A3KO mouse aorta (data not
shown), suggesting that A3AR activation enhances Nox2 pro-
tein expression at a post-transcriptional level.
Fig. 2. Effects of apocynin and DPI (A) and MRS1523 (B) on Cl-IBMECA-
induced ROS generation in WT and A3KO mouse aorta. Data are ex-
pressed as the mean  S.E.M. (n  4). , p 	 0.05 compared with the
corresponding WT control group using an unpaired t test.
Fig. 3. Effects of Cl-IBMECA on protein expression of Nox2 subunit in
WT (A) and A3KO (B) mouse aorta. Data are expressed as the mean 
S.E.M. (n  3). , p 	 0.05 compared with control; $, p 	 0.05 compared
with Cl-IBMECA alone using one-way ANOVA followed by a Tukey
multiple comparisons post hoc test.
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Discussion
This is the first study to show that Nox are involved in
A3AR-induced contraction of mouse aorta. However, other
studies have shown a relationship between adenosine recep-
tors and Nox in other tissues (Carlstrom et al., 2009; Ge-
bremedhin et al., 2010) but not in aorta. Our findings show
that A3AR activation using the selective agonist Cl-IBMECA
causes contraction of aorta in WT mice but not in A3KO mice.
This A3AR-mediated contraction of aorta was inhibited by a
Nox inhibitor (apocynin), in addition to ROS scavengers
PEG-SOD and PEG-catalase, and was not affected by the
mast cell degranulator compound 48/80 or the stabilizer
cromolyn sodium. We also found that A3AR activation leads
to increased intracellular ROS generation, which was inhib-
ited by apocynin, DPI, and the selective A3AR antagonist,
MRS1523. Furthermore, the protein expression of Nox2 sub-
unit was selectively increased by Cl-IBMECA in WT but not
in A3KO mice aorta without affecting either Nox1 or 4.
We used the pharmacological selective A3AR agonist Cl-
IBMECA, in addition to A3KO mice to confirm that A3AR
activation induces aortic contraction in WT mice. The role of
A3AR in the control of vascular tone has also been demon-
strated by our laboratory (Ansari et al., 2007b). In another
study, infusion of adenosine in A3KO mice has been shown to
cause a significant decrease in blood pressure compared with
that in WT mice (Zhao et al., 2000). In addition, the effects of
A3AR activation on vascular tone have also been demon-
strated through inhibition or negative modulation of coro-
nary flow in isolated mouse heart (Talukder et al., 2002),
vasoconstriction in hamster arterioles (Shepherd et al.,
1996), and reversal of vascular hyporeactivity after hemor-
rhagic shock in rats (Zhou et al., 2010).
It should be noted that mast cells can be stimulated by
A3AR to release histamine and thromboxane, leading to ei-
ther vasoconstriction (Shepherd et al., 1996) or a short-last-
ing hypotension in conscious rats (Van Schaick et al., 1996).
Fig. 4. Effects of Cl-IBMECA on protein expression of Nox1 in WT (A), Nox1 in A3KO (B), Nox4 in WT (C), and Nox4 in A3KO (D) mouse aorta. Data
are expressed as the mean  S.E.M. (n  3).
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Our data show that neither the mast cell degranulator (com-
pound 48/80) nor stabilizer (cromolyn sodium) affected A3AR-
induced contraction, suggesting that mast cells may not play
a significant role in our model.
In the present work, apocynin significantly reduced the
contraction induced by Cl-IBMECA, suggesting that A3AR-
induced contraction in mouse aorta involves Nox. We have
shown previously that COX-1 plays a role in this A3AR re-
sponse (Ansari et al., 2007b); therefore, it is likely that there
may be a relationship between Nox and COX-1. Nox activity
has been shown to be activated through the arachidonic acid
pathway in cardiac fibroblasts (Colston et al., 2005). In ad-
dition, ROS derived from Nox can induce COX-2 protein in
human neutrophils (Vega et al., 2006), suggesting an inter-
action between Nox and COX pathways. Taken together,
these data along with our data indicate that A3AR may play
an important role in the regulation of vascular tone, mainly
through endothelium-dependent pathways.
A3ARs have been shown to be involved in the modulation of
diseases involving ROS generation such as ischemia-reper-
fusion injury (Maddock et al., 2003; Zatta et al., 2006), sug-
gesting that A3AR effects may be related to ROS generation.
It has been shown that adenosine constricts renal arterioles
of WT but not Nox KO mice (Carlstrom et al., 2009), whereas
its cerebral vasodilation in rat involves Nox (Gebremedhin et
al., 2010). Furthermore, A3ARs have been shown to modulate
Nox activity in monocytes (Broussas et al., 1999) and in
prostate cancer cells (Jajoo et al., 2009). Our results show
that A3AR induces ROS production that was inhibited by
apocynin and DPI. In addition, Cl-IBMECA induced selective
protein expression of Nox2 subunit only in WT but not in
A3KO animals without affecting Nox1 or 4, suggesting that
A3AR induces ROS generation, possibly through the activa-
tion of Nox2.
We previously demonstrated that activation of A3AR leads
to endothelium-dependent aortic contraction (Ansari et al.,
2007b). However, because Nox isoforms are expressed in both
endothelium and vascular smooth muscle, further studies
are needed to differentiate the role of each cell type in A3AR-
induced ROS generation.
Of interest, the protein expression of Nox2 was increased
by Cl-IBMECA, but the mRNA was not affected, suggesting
that activation of A3AR enhances Nox2 protein expression
through post-transcriptional response, such as changes in
protein translation and/or turnover. This finding may also
partly explain the rapid change in Nox2 protein expression
by short-term exposure to Cl-IBMECA. However, a direct
correlation between this rapid change in Nox2 protein and
vascular contraction requires further confirmation. Rapid
changes in gene and protein expression patterns have been
shown within minutes of tissue ischemia after surgical tumor
excision (Spruessel et al., 2004). In addition, up-regulation of
different cellular proteins due to changes in the translational
level or protein turnover without changes in mRNA expres-
sion has been shown (Burd et al., 2008; Yoshimura et al.,
2008).
Vascular Nox are activated within minutes of stimulation
(Seshiah et al., 2002), with different species of ROS produced,
mainly superoxide anions (O2
). This O2
 can enhance va-
soconstriction by rapidly converting nitric oxide to the much
less vasodilator peroxynitrite (Koppenol et al., 1992). The
ROS indicator DCFH-DA used in this study is nonspecific
because it can detect several ROS such as O2
, hydrogen
peroxide (H2O2), and hydroxyl radicals (Biziukin et al.,
1995). However, because most Nox isoforms produce O2
 as
a main ROS; therefore, our data indicate that A3AR possibly
enhances O2
 production through Nox2, which may play an
important role in the vasoconstriction induced by A3AR in
the mouse aorta. Further studies are needed to identify the
various ROS produced by the activation of A3AR.
In the literature, some concerns were raised about the
selectivity of Nox inhibitors such as apocynin (Schlüter et al.,
2008) and DPI (Stuehr et al., 1991), which may affect the
results obtained with these inhibitors in our study. There-
fore, use of these inhibitors solely may present some argu-
ments about their specific targets. To address this issue, our
studies used not only these inhibitors but also ROS genera-
tion and Nox subunit protein expression as tools to confirm
the relationship between A3AR and Nox.
Because ROS are involved in several diseases and A3AR
modulators have been tested in some diseases such as renal
cancer (Jajoo et al., 2009), a better understanding of the
relationship between A3AR and ROS generation, possibly
through Nox, may result in potential therapeutic targets in
cardiovascular pathophysiological situations involving higher
oxidative stress. In addition, this study shows that Nox inhibi-
tors can be used to attenuate the vasoconstrictor responses to
A3AR; therefore, enhancement of the vasodilator responses of
adenosine through A2A/BAR (relaxing receptors) could be bene-
ficial in conditions such as hypertension and coronary artery
diseases.
In conclusion, A3AR activation induces contraction of the
mouse aorta that is dependent on ROS generation, possibly
mediated through Nox2.
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